Growth Metrics

Tandem Diabetes Care (TNDM) Depreciation & Amortization (CF) (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Depreciation & Amortization (CF) for 13 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 5.89% year-over-year to $4.5 million, compared with a TTM value of $17.7 million through Dec 2025, up 6.38%, and an annual FY2025 reading of $17.7 million, up 6.38% over the prior year.
  • Depreciation & Amortization (CF) was $4.5 million for Q4 2025 at Tandem Diabetes Care, roughly flat from $4.5 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $4.5 million in Q4 2025 and bottomed at $3.4 million in Q1 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $3.9 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 90.44% in 2021, then decreased 6.39% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $3.5 million in 2021, then increased by 3.44% to $3.6 million in 2022, then increased by 10.71% to $4.0 million in 2023, then rose by 5.31% to $4.2 million in 2024, then increased by 5.89% to $4.5 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for TNDM at $4.5 million in Q4 2025, $4.5 million in Q3 2025, and $4.4 million in Q2 2025.